Latest Breaking News On - Vascular science - Page 1 : vimarsana.com

Humacyte Second Quarter 2023 Financial Results and Business Update

Humacyte Second Quarter 2023 Financial Results and Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLaura niklasonHumacyte incHealth system research symposiumTrauma centersAlpha healthcare acquisition corpHumacyte inc condensed consolidated balance sheetsJoyce allairelifesci advisorsVascular trauma humanitarian programHumacyte inc condensed consolidated statements of operationsDrug administrationDiabetes researchCompleted enrollmentVascular trauma repairTop line resultsUkraine highlighted

Humacyte Announces Publication of Biological Mechanism Explaining Low Rates of Infection Observed in Clinical Study of Human Acellular Vessel™ (HAV™)

Results published in Journal of Vascular Surgery – Vascular Science DURHAM, N.C., Aug. 03, 2023 Humacyte, Inc. , a clinical-stage biotechnology platform company developing universally.

United statesJoyce allaireLaura niklasonHumacyte incGlobenewswire incLifesci advisorsVascular surgeryVascular scienceBiological mechanismsInfection resistanceTissue engineered blood vessels comparedMedicine advanced therapyAnnual reportInvestor contactMedia contact

Humacyte (HUMA) Announces Publication of Biological Mechanism Explaining Low Rates of Infection Observed in Clinical Study of Human Acellular Vessel

Humacyte (HUMA) Announces Publication of Biological Mechanism Explaining Low Rates of Infection Observed in Clinical Study of Human Acellular Vessel
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLaura niklasonHumacytehumacyte incHumacyte incJoyce allairelifesci advisorsVascular surgeryVascular scienceBiological mechanismsInfection resistanceTissue engineered blood vessels comparedMedicine advanced therapyAnnual reportInvestor contactMedia contactRich luchetteprecision

Instylla Announces Positive Results From Preclinical Studies of Embrace Hydrogel Embolic System in Hemorrhage Models

Instylla Announces Positive Results From Preclinical Studies of Embrace Hydrogel Embolic System in Hemorrhage Models
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAmber voelkerDavids kauvarTimothy jarrettEric john gandrasRaymond lareauMichaela dubickBijans kheirabadiI amy polykratisEric gandrasInstylla incInterventional radiology at north shore university hospitalEmbrace hydrogel embolic systemInterventional radiologyAssociate chief

Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models

/PRNewswire/ Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced two.

New yorkUnited statesAmber voelkerDavids kauvarTimothy jarrettEric john gandrasRaymond lareauMichaela dubickBijans kheirabadiI amy polykratisEric gandrasInstylla incInterventional radiology at north shore university hospitalPrnewswire instylla incHydrogel embolic systemInterventional radiology